Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of metabolism/homeostasis (HP:0001939)help
Parent Node:
expand
Abnormal circulating protein concentration (HP:0010876)help
..Starting node
..expand
Abnormal circulating beta globulin level (HP:0025465)help
Term ID: 25465
Name: Abnormal circulating beta globulin level
Synonym:
Definition: A deviation from the normal concentration of beta globulin. The beta globulins are a group of globular (globe-shaped) proteins in blood.
Comments:
Reference: HP:0025465
Genes and Diseases:
 
       Child Nodes:
........expandAtransferrinemia (HP:0012239) help
........expandAbnormality of circulating beta-2-microglobulin level (HP:0025345) help
................... HP:0025346 Increased circulating beta-2-microglobulin level
................... HP:0025347 Decreased circulating beta-2-microglobulin level
........expandAbnormal circulating properdin level (HP:0031300) help
........expandAbnormal sex hormone-binding globulin level (HP:0031438) help
........expandAbnormal angiostatin level (HP:0031439) help
........expandDecreased level of plasminogen (HP:0040228) help

 Sister Nodes: 
..expandAbnormal B-type natriuretic peptide level (HP:0031138) help
..expandAbnormal circulating albumin concentration (HP:0012116) help
..expandAbnormal circulating apolipoprotein concentration (HP:0025201) help
..expandAbnormal circulating beta-C-terminal telopeptide concentration (HP:0031424) help
..expandAbnormal circulating thyroglobulin level (HP:0025483) help
..expandAbnormal hepcidin level (HP:0031875) help
..expandAbnormal insulin like growth factor binding protein acid labile subunit level (HP:0031034) help
..expandAbnormal levels of alpha-fetoprotein (HP:0045056) help
..expandAbnormal retinol-binding protein level (HP:0031031) help
..expandAbnormality of circulating enzyme level (HP:0011021) help
..expandAbnormality of the kinin-kallikrein system (HP:0005559) help
..expandDecreased prealbumin level (HP:0031085) help
..expandElevated carcinoembryonic antigen level (HP:0031029) help
..expandElevated carcinoma antigen 125 level (HP:0031030) help
..expandElevated circulating C-reactive protein concentration (HP:0011227) help
..expandElevated prostate-specific antigen level (HP:0025020) help
..expandHyperpepsinogenemia I (HP:0003238) help
..expandHyperproteinemia (HP:0002152) help
..expandHypoproteinemia (HP:0003075) help
..expandIncreased circulating thyroxine-binding globulin level (HP:0031222) help
..expandReduced growth-hormone binding protein level (HP:0031036) help
..expandReduced insulin-like factor 3 level (HP:0031037) help
..expandReduced sex -hormone binding protein level (HP:0031419) help
..expandReduced thyroxin-binding globulin (HP:0012509) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0025465HP:0025465Abnormal circulating beta globulin level0ALB CL E G H213399OMIM:616000Analbuminemia104
HP:0025465HP:0025465Abnormal circulating beta globulin level0B2M CL E G H567914OMIM:241600Immunodeficiency 438
HP:0025465HP:0025465Abnormal circulating beta globulin level0CIITA CL E G H42617067ORPHA:572Immunodeficiency by defective expression of MHC class II118
HP:0025465HP:0025465Abnormal circulating beta globulin level0RFX5 CL E G H59939986ORPHA:572Immunodeficiency by defective expression of MHC class II38
HP:0025465HP:0025465Abnormal circulating beta globulin level0RFXANK CL E G H86259987ORPHA:572Immunodeficiency by defective expression of MHC class II26
HP:0025465HP:0025465Abnormal circulating beta globulin level0RFXAP CL E G H59949988ORPHA:572Immunodeficiency by defective expression of MHC class II34
HP:0025465HP:0025465Abnormal circulating beta globulin level0TF CL E G H701811740OMIM:209300ATRANSFERRINEMIA45
HP:0025465HP:0031439Abnormal angiostatin level1 CL E G H
HP:0025465HP:0031438Abnormal sex hormone-binding globulin level1 CL E G H
HP:0025465HP:0031300Abnormal circulating properdin level1 CL E G H
HP:0025465HP:0032385Abnormal circulating transferrin concentration1ALB CL E G H213399OMIM:616000Analbuminemia104
HP:0025465HP:0025345Abnormality of circulating beta-2-microglobulin level1B2M CL E G H567914OMIM:241600Immunodeficiency 438
HP:0025465HP:0025345Abnormality of circulating beta-2-microglobulin level1CIITA CL E G H42617067ORPHA:572Immunodeficiency by defective expression of MHC class II118
HP:0025465HP:0025345Abnormality of circulating beta-2-microglobulin level1RFX5 CL E G H59939986ORPHA:572Immunodeficiency by defective expression of MHC class II38
HP:0025465HP:0025345Abnormality of circulating beta-2-microglobulin level1RFXANK CL E G H86259987ORPHA:572Immunodeficiency by defective expression of MHC class II26
HP:0025465HP:0025345Abnormality of circulating beta-2-microglobulin level1RFXAP CL E G H59949988ORPHA:572Immunodeficiency by defective expression of MHC class II34
HP:0025465HP:0032385Abnormal circulating transferrin concentration1TF CL E G H701811740OMIM:209300ATRANSFERRINEMIA45
HP:0025465HP:0032387Reduced circulating transferrin concentration2 CL E G H
HP:0025465HP:0025346Increased circulating beta-2-microglobulin level2 CL E G H
HP:0025465HP:0032386Elevated circulating transferrin concentration2ALB CL E G H213399OMIM:616000Analbuminemia104
HP:0025465HP:0025347Decreased circulating beta-2-microglobulin level2B2M CL E G H567914OMIM:241600Immunodeficiency 438
HP:0025465HP:0025347Decreased circulating beta-2-microglobulin level2CIITA CL E G H42617067ORPHA:572Immunodeficiency by defective expression of MHC class IIHP:0040282 - Frequent118
HP:0025465HP:0025347Decreased circulating beta-2-microglobulin level2RFX5 CL E G H59939986ORPHA:572Immunodeficiency by defective expression of MHC class IIHP:0040282 - Frequent38
HP:0025465HP:0025347Decreased circulating beta-2-microglobulin level2RFXANK CL E G H86259987ORPHA:572Immunodeficiency by defective expression of MHC class IIHP:0040282 - Frequent26
HP:0025465HP:0025347Decreased circulating beta-2-microglobulin level2RFXAP CL E G H59949988ORPHA:572Immunodeficiency by defective expression of MHC class IIHP:0040282 - Frequent34
HP:0025465HP:0012239Atransferrinemia2TF CL E G H701811740OMIM:209300ATRANSFERRINEMIA.45


Genes (7) :ALB B2M CIITA RFX5 RFXANK RFXAP TF

Diseases (4) :OMIM:616000 OMIM:241600 ORPHA:572 OMIM:209300
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.